MaxiVAX SA
3 articles about MaxiVAX SA
-
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.
-
MaxiVAX awarded €2,785,000 European Commission grant and announces successful closing of its Series B 2 round for an amount of CHF 5 million
11/26/2019
MaxiVAX wins grant among 94 projects funded out of 2,015 applications
-
MaxiVAX SA Release: Swiss Biotech Starts Breakthrough Anti-Cancer Clinical Trial Based On Active Immunotherapy
11/13/2014